[1]EUGENE R, SCHIFF, MICHAEL F. Schiff's hepatology[M].1th, HUANG ZQ. Beijing:Chemical Industry Press, 2006:263. (in Chinese) Eugene R, Schiff, Michael F.希夫肝脏病学[M]. 1版, 黄志强, 译.北京:化学工业出版社, 2006:263.
|
[2]ALLAN R, THOIRS K, PHILLIPS M. Accuracy of ultrasound to identify chronic liver disease[J]. World J Gastroenterol, 2010, 16 (28) :3510-3520.
|
[3]CHEN YP, DAI L, WANG JL, et al. Model consisting of ultrasonographic and simple blood indexes accurately identify compensated hepatitis B cirrhosis[J]. J Gastroenterol Hepatol, 2008, 23 (8) :1228-1234.
|
[4]HUNG CH, LU SN, WANG JH, et al. Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis[J]. J Gastroenterol, 2003, 38 (2) :153-157.
|
[5]MOON KM, KIM G, BAIK SK, et al. Ultrasonographic scoring system score versus liver stiffness measurement in prediction of cirrhosis[J]. Clin Mol Hepatol, 2013, 19 (4) :389-398.
|
[6]BARR RG, FERRAIOLI G, PALMERI ML, et al. Elastography assessment of liver fibrosis, society of radiologists in ultrasound consensus conference statement[J]. Ultrasound Q, 2016, 32 (2) :94-107.
|
[7]FERRAIOLI G, WONG VWS, CASTERA L, et al. Liver Ultrasound elastography:An update to the world federation for ultrasound in medicine and biology guideline and recommendation[J]. Ultrasound Med Biol, 2018, 44 (12) :2419-2440.
|
[8]FRAQUELLI M, RIGAMONTI C, CASAZZA G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease[J]. Gut, 2007, 56:968-973.
|
[9]CHEN YP, PENG J, HOU JL. Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B[J]. Hepatol Int, 2013, 7 (2) :356-368.
|
[10]Review Panel for Liver Stiffness Measurement. Recommendations for the clinical application of transient elastography in liver fibrosis assessment[J]. Chin J Hepatol, 2013, 21 (6) :420-424. (in Chinese) 肝脏硬度评估小组.瞬时弹性成像技术诊断肝纤维化专家意见[J].中华肝脏病杂志, 2013, 21 (6) :420-424.
|
[11]LIANG XE, CHEN YP, ZHANG Q, et al. Dynamic evaluation paralleled with bilirubin and ALT normalization to improve diagnostic accuracy of Fibroscan in patients with hepatitis B exacerbation[J]. J Viral Hepat, 2011, 18 (12) :884-891.
|
[12] CHAN HL, WONG GL, CHOI PC, et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B[J]. J Viral Hepat, 2009, 16 (1) :36-44.
|
[13]CHEN YP, LIANG XE, DAI L, et al. Improving transient elastography performance for detecting hepatitis B cirrhosis[J].Dig Liver Dis, 2012, 44 (1) :61-66.
|
[14]CHEN YP, LIANG XE, ZHANG Q, et al. Larger biopsies evaluation of transient elastography for detecting advanced fibrosis in patients with compensated chronic hepatitis B[J]. J Gastroenterol Hepatol, 2012, 27 (7) :1219-1226.
|
[15]HALL TJ, MILKOWSKI A, GARRA B, et al. RSNA/QIBA:Shear wave speed as a biomarker for liver fibrosis staging[J]. Ultrasonics Symposium (IUS) , 2013, 2013:397-400.
|
[16]FRIEDRICH-RUST M, NIERHOFF J, LUPSOR M, et al. Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis:A pooled meta-analysis[J]. J Viral Hepat, 2012, 19 (2) :e212-e219.
|
[17]BOTA S, HERKNER H, SPOREA I, et al. Meta-analysis:ARFI elastography versus transient elastography for the evaluation of liver fibrosis[J]. Liver Int, 2013, 33 (8) :1138-1147.
|
[18]HUANG Z, ZHENG J, ZENG J, et al. Normal liver stiffness in healthy adults assessed by real-time shear wave elastography and factors that influence this method[J]. Ultrasound Med Biol, 2014, 40 (11) :2549-2555.
|
[19]LEUNG VY, SHEN J, WONG VW, et al. Quantitative elastography of liver fibrosis and spleen stiffness in chronic hepatitis B carriers:Comparison of shear-wave elastography and transient elastography with liver biopsy correlation[J]. Radiology, 2013, 269 (3) :910-918.
|
[20]CASSINOTTO C, LAPUYADE B, MOURIES A, et al. Non-invasive assessment of liver fibrosis with impulse elastography:Comparison of supersonic shear imaging with ARFI and FibroScan[J]. J Hepatol, 2014, 61 (3) :550-557.
|
[21]MANNING DS, AFDHAL NH. Diagnosis and quantitation of fibrosis[J]. Gastroenterology, 2008, 134 (6) :1670-1681.
|
[22]HOODESHENAS S, YIN M, VENKATESH SK. Magnetic resonance elastography of liver:Current update[J]. Top Magn Reson Imaging, 2018, 27 (5) :319-333.
|
[23]SINGH S, VENKATESH SK, WANG Z, et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis:A systematic review and meta-analysis of individual participant data[J]. Clin Gastroenterol Hepatol, 2015, 13 (3) :440-451. e6.
|
[24] WANLESS IR, NAKASHIMA E, SHERMAN M, et al. Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis[J]. Arch Pathol Lab Med, 2000, 12490 (11) :1599-1607.
|
[25]HYTIROGLOU P, THEISE ND. Regression of human cirrhosis:An update, 18 years after the pioneering article by Wanless et al[J]. Virchows Archiv, 2018, 473 (1) :15-22.
|
[26]ENOMOTO M, MORI M, OGAWA T, et al. Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B:Regression of liver stiffness during entecavir therapy[J]. Hepatol Res, 2010, 40 (9) :853-861.
|
[27]WONG GL, WONG VW, CHOI PC, et al. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients[J]. Antivir Ther, 2011, 16 (2) :165-172.
|
[28]DONG XQ, WU Z, LI J, et al. Declining in liver stiffness can not indicate fibrosis regression in patients with chronic hepatitis B:A 78-week prospective study[J]. J Gastroenterol Hepatol, 2018.[Epub ahead of print]
|
[29]LIANG X, TAN D, XIE Q, et al. Interpretation of liver stiffness measurement-based approach for the monitoring of hepatitis B patients with antiviral therapy:A 2-year prospective study[J]. J Viral Hepat, 2018, 25 (3) :296-305.
|
[30]CHAN HL, WONG GL, CHOI PC, et al. Alanine aminotransferasebased algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B[J]. J Viral Hepat, 2009, 16 (1) :36-44.
|
[31] SUN Y, ZHOU J, WANG L, et al. New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment[J]. Hepatology, 2017, 65 (5) :1438-1450.
|
[32]KONG Y, SUN Y, ZHOU J, et al. Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir[J]. J Viral Hepat, 2019.[Epub ahead of print]
|
[33]MAURO E, CRESPO G, MONTIRONI C, et al. Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C[J]. Hepatology, 2018, 67 (5) :1683-1694.
|
[34]HARTL J, EHLKEN H, SEBODE M, et al. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis[J]. J Hepatol, 2018, 68 (4) :754-763.
|
[35]European Association for the Study of the Liver, Asociación Latinoamericana parael Estudio del Hígado. EASL-ALEH clinical practice guidelines:Non-invasive tests for evaluation of liver disease severity and prognosis[J]. J Hepatol, 2015, 63:237-264.
|
[36]PINZANI M. Liver fibrosis in the post-HCV era[J]. Semin Liver Dis, 2015, 35 (2) :157-165.
|
[37]WU S, KONG Y, PIAO H, et al. On-treatment changes of liver stiffness at week 26 could predict 2-year clinical outcomes in HBV-related compensated[J]. Liver Int, 2018, 38 (6) :1045-1054.
|
[38]HEZODE C, CASTERA L, ROUDOT-THORAVAL F, et al. Liver stiffness diminishes with antiviral response in chronic hepatitis C[J]. Aliment Pharmacol Ther, 2011, 34 (6) :656-663.
|
[39]KIM SU, PARK JY, KIM DY, et al. Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B:Impact of antiviral treatment on fibrosis regression[J]. Hepatol Int, 2010, 4 (4) :673-680.
|
[40]D’AMBROSIO R, AGHEMO A, FRAQUELLI M, et al. The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response[J]. J Hepatol, 2013, 59 (2) :251-256.
|